Niagen Bioscience, Inc. (NAGE)

NASDAQ: NAGE · Real-Time Price · USD

3.020

-0.030 (-0.98%)

At close: Aug 14, 2026, 4:00 PM EDT

3.040

+0.020 (0.66%)

After-hours: Aug 14, 2026, 7:42 PM EDT

Niagen Bioscience Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	129.08	129.42	99.6	83.57	72.05	67.45
Revenue Growth	10.99%	29.95%	19.18%	15.99%	6.82%	13.83%
Gross Profit	82.92	83.19	61.59	50.78	42.8	41.49
Operating Income	8.62	14.3	7.73	-5.6	-18.63	-27.07
Net Income	15.99	17.38	8.55	-4.94	-16.54	-27.13
Earnings Per Share	0.19	0.20	0.11	-0.07	-0.24	-0.40
EPS Growth	-11.65%	81.82%	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Consumer Products	100.05	97.67	76.77	69.53	60.11	56.71
Ingredients	26.84	28.68	19.81	11.14	8.74	7.41
Analytical Reference Standards and Services	1.89	3.08	3.01	2.91	3.2	3.34
Total	129.08	129.42	99.6	83.57	72.05	67.45

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	66.59	64.64	44.51	27.17	20.29	28.02
Total Debt	2.33	2.82	2.65	3.28	4.26	4.7
Net Cash (Debt)	64.26	61.82	41.86	23.9	16.03	23.32
Net Cash Growth	12.68%	47.69%	75.16%	49.05%	-31.24%	56.91%
Net Cash Per Share	0.76	0.72	0.54	0.32	0.23	0.35

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	5.95	13.5	12.11	7.12	-15.1	-24.16
Capital Expenditures	-0.28	-0.29	-0.16	-0.15	-0.33	-0.41
Free Cash Flow	5.67	13.21	11.95	6.97	-15.43	-24.57
Free Cash Flow Growth	-72.90%	10.60%	71.42%	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	64.24%	64.28%	61.83%	60.76%	59.40%	61.51%
Operating Margin	6.67%	11.05%	7.76%	-6.70%	-25.85%	-40.14%
Pretax Margin	13.19%	14.06%	8.89%	-5.91%	-22.96%	-40.22%
Profit Margin	12.39%	13.43%	8.58%	-5.91%	-22.96%	-40.22%
FCF Margin	4.40%	10.21%	11.99%	8.34%	-21.42%	-36.43%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	15.88	29.26	47.50	-	-	-
Forward PE	32.83	27.81	50.28	160.00	160.00	160.00
P/FCF Ratio	42.20	38.50	33.99	15.45	-	-
PS Ratio	1.86	3.93	4.08	1.29	1.74	3.79